Global Vertebroplasty and Kyphoplasty Devic Market Size By Type (Vertebroplasty, Kyphoplasty), By Application (Hospital, Ambulatory Surgery Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Vertebroplasty and Kyphoplasty Device Market was valued at USD 1.12 billion in 2023 and is projected to reach USD 2.03 billion by 2031, growing at a CAGR of 7.8% during the forecast period (2023–2031). The increasing prevalence of osteoporosis and spinal compression fractures, along with advancements in minimally invasive spinal surgeries, are propelling market growth. Both vertebroplasty and kyphoplasty procedures offer pain relief and structural support for vertebral fractures, particularly in geriatric populations, thereby gaining rapid adoption across healthcare systems worldwide.

Drivers:

1. Growing Geriatric Population and Osteoporosis Incidence:

An aging population is directly linked to an increase in osteoporosis-related vertebral compression fractures (VCFs), creating sustained demand for vertebroplasty and kyphoplasty devices.

2. Rise in Minimally Invasive Procedures:

These procedures offer faster recovery, reduced hospital stays, and minimal surgical complications, contributing to higher adoption rates in hospitals and outpatient settings.

3. Technological Advancements in Device Design:

Enhanced balloon catheters, image-guided navigation systems, and bone cement materials are improving procedural precision and outcomes, encouraging healthcare providers to adopt these therapies.

Restraints:

1. High Procedure and Equipment Costs:

The cost of advanced kyphoplasty kits and imaging guidance systems may limit accessibility, particularly in low- and middle-income countries.

2. Risks and Complications:

Despite being minimally invasive, potential complications such as cement leakage, adjacent vertebral fractures, and neurological issues remain concerns that could affect procedure acceptance.

Opportunity:

1. Expansion in Emerging Economies:

Improved healthcare infrastructure and growing awareness about spinal treatments in countries such as India, Brazil, and Indonesia present untapped growth avenues.

2. Integration with Robotic and Image-Guided Technologies:

Combining vertebroplasty/kyphoplasty devices with AI-enabled navigation and robotic surgery platforms can enhance accuracy and outcomes, offering a competitive edge to innovators.

Market by System Type Insights:

Kyphoplasty Devices held the dominant share in 2023, owing to better vertebral height restoration and spinal alignment correction. The segment benefits from ongoing enhancements in inflatable balloon technology and minimally invasive tools. However, vertebroplasty devices are witnessing steady growth due to their cost-effectiveness and simpler procedural workflow, particularly in developing healthcare systems.

Market by End-use Insights:

Hospitals remain the primary end-users due to their access to specialized surgeons and high-end imaging technologies. This segment accounted for over 55% of total revenue in 2023. Meanwhile, ambulatory surgical centers (ASCs) are emerging as fast-growing facilities, offering same-day procedures with reduced hospitalization costs.

Market by Regional Insights:

North America led the global vertebroplasty and kyphoplasty device market in 2023, supported by a high geriatric population, strong reimbursement frameworks, and advanced surgical infrastructure. Asia-Pacific is anticipated to register the fastest CAGR through 2031, driven by increasing osteoporosis prevalence, healthcare expansion, and medical tourism in countries like China and India.

Competitive Scenario:

Key players in the Global Vertebroplasty and Kyphoplasty Device Market include:

Medtronic plc

Stryker Corporation

Globus Medical, Inc.

Johnson & Johnson (DePuy Synthes)

Merit Medical Systems, Inc.

Zimmer Biomet

IZI Medical Products

G21 S.r.l.

These companies are investing in R&D, regulatory approvals, and geographic expansions. For instance:

In 2023, Stryker introduced a next-gen bone cement injector with pressure monitoring capabilities.

Medtronic expanded its portfolio in 2022 by acquiring a start-up specializing in AI-based spinal navigation tools.

Scope of Work – Global Vertebroplasty and Kyphoplasty Device Market

Report Metric Details

Market Size (2023) USD 1.12 billion

Projected Market Size (2031) USD 2.03 billion

CAGR (2023–2031) 7.8%

Market Segments System Type (Vertebroplasty, Kyphoplasty), End-use (Hospitals, ASCs)

Growth Drivers Aging population, osteoporosis prevalence, minimally invasive procedure demand

Opportunities Emerging markets expansion, AI-integrated navigation systems

Key Market Developments:

April 2024 – Medtronic received FDA approval for a robotic-assisted kyphoplasty platform designed for outpatient use.

December 2023 – Globus Medical launched its VerteLift 2.0 system with upgraded balloon technology for enhanced vertebral height restoration.

August 2023 – Zimmer Biomet partnered with AI imaging startup to optimize real-time guidance in spine procedures.

FAQs:

1) What is the current market size of the Global Vertebroplasty and Kyphoplasty Device Market?

The market was valued at USD 1.12 billion in 2023.

2) What is the major growth driver of the Global Vertebroplasty and Kyphoplasty Device Market?

The key growth driver is the rising incidence of osteoporosis-related spinal fractures and the preference for minimally invasive procedures.

3) Which is the largest region during the forecast period in the Global Vertebroplasty and Kyphoplasty Device Market?

North America is expected to remain the dominant region due to its advanced healthcare infrastructure.

4) Which segment accounted for the largest market share in Global Vertebroplasty and Kyphoplasty Device Market?

The Kyphoplasty device segment led the market in 2023 owing to superior spinal restoration benefits.

5) Who are the key market players in the Global Vertebroplasty and Kyphoplasty Device Market?

Major players include Medtronic, Stryker, Globus Medical, Johnson & Johnson, and Zimmer Biomet.